SELLAS is a clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications

Our patented technology with embedded AI collects and clinically organizes patient data, including records, lab results, images...

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent...